Thermo Fisher Scientific (TMO) Tops Q4 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Raymond James Reiterates Outperform Rating on Thermo Fisher Scientific (TMO)
January 30, 2025 6:55 AM ESTRaymond James analyst Andrew Cooper reiterated an Outperform rating and $650.00 price target on Thermo Fisher Scientific (NYSE: TMO).
The analyst comments "This morning, Thermo Fisher reported 4Q24 results which were ahead on revenues overall (+4% organic vs. sub-3% Street), with profitability following suit, landing adjusted EPS $0.15 above consensus. These results are... More
